Results 221 to 230 of about 31,119,208 (308)

Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.

Urol Int
Filzmayer M, Quarta L, Petix M, Orlandi F, Goyal JA, Briganti A, Carmignani L, Micali S, Shariat SF, Kosiba M, Traumann MI, Humke C, Saad F, Chun FK, Karakiewicz PI.   +14 more
europepmc   +1 more source

HbA1c and pulmonary function in type 2 diabetes mellitus: A systematic review and meta-analysis. [PDF]

PLoS One
Atmaja KS, Masyeni S, Dewi SL, Putri PD.
europepmc   +1 more source

Coronary Perforation During Excimer Laser Angioplasty in a Patient With Prior Thoracic Radiotherapy

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Management of heavily calcified coronary lesions remains challenging despite advances in plaque‐modifying technologies. Excimer laser coronary angioplasty (ELCA) is an effective adjunctive strategy with a low risk of no‐reflow. Case Summary A 75‐year‐old woman with non–ST‐segment elevation acute coronary syndrome and severe left ...
Francesco Maria Sparasci, Alessandro Cafaro, Dionigi Fischetti, Alessandro Mandurino‐Mirizzi   +3 more
wiley   +1 more source

Cognitive Impairment in People with Type 2 Diabetes Mellitus: Associations with Inflammatory and Vascular Markers. [PDF]

Ann Neurosci
Soni S, Bj SC, Manohar S, P C PK.
europepmc   +1 more source

Final 2‐Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In‐Stent Restenosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In the REFORM trial, treatment of coronary in‐stent restenosis with a Biolimus A9™ drug‐coated balloon (BCB) was found to be inferior with respect to in‐segment percentage stenosis at 6‐months in comparison to treatment with a standard paclitaxel coated paclitaxel‐coated balloon (PCB). Aims In this manuscript, the final prespecified
Daniel O'Callaghan, J. J. Coughlan, Fernando Alfonso, Joo‐Yong Hahn, Manel Sabate, Ralph Toelg, Samuel Copt, Sean Fitzgerald, Marie‐Claude Morice, Jasper Trevelyan, Darren Mylotte, Antonio Fernandez Ortiz, Rory Durand, Jochen Wöhrle, Franz Xever Kleber, Giuilo Stefanini, Himanshu Rai, Peter O'Kane, Robert A. Byrne   +18 more
wiley   +1 more source

Hypothalamic Inflammaging: A Central Driver of Type 2 Diabetes Mellitus and Metabolic Disease in Aging. [PDF]

Diabetes Metab J
Lyoo SH, Kim KH, Kim KW.
europepmc   +1 more source

Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens, Florian Schindhelm, Mohammed Abusharekh, Jürgen Kampf, Matthias Totzeck, Fadi Al‐Rashid, Peter Lüdike, Tienush Rassaf, Amir A. Mahabadi   +8 more
wiley   +1 more source

Association between atherogenic index of plasma and depression in patients with type 2 diabetes mellitus: A cross-sectional study. [PDF]

Medicine (Baltimore)
Feng X, Ding L, Wu X.
europepmc   +1 more source

Sheath‐to‐Artery Diameter Ratio: A Robust Predictor of Early Access‐Site Adverse Events in Percutaneous Procedures

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Vascular access site complications (VASCs) remain an important source of morbidity following percutaneous interventions. Although the sheath‐to‐femoral artery ratio is a recognized risk factor in transcatheter aortic valve implantation (TAVI), its role across a broader range of femoral procedures is less well defined.
Eduardo Ismael Arteaga Chan, Claudia Lerma, Adriana Torres‐Machorro   +2 more
wiley   +1 more source